Sonali Smith to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Sonali Smith has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.767
-
Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials. Lancet Haematol. 2017 Apr; 4(4):e176-e182.
Score: 0.292
-
Maintenance rituximab revisited: is it worth the cost? Leuk Lymphoma. 2012 Dec; 53(12):2331-2.
Score: 0.211
-
Recombinant interferon-alpha2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691. Leuk Lymphoma. 2009 Oct; 50(10):1606-17.
Score: 0.174
-
The anti-CD80 primatized monoclonal antibody, galiximab, is well-tolerated but has limited activity in relapsed Hodgkin lymphoma: Cancer and Leukemia Group B 50602 (Alliance). Leuk Lymphoma. 2013 Jul; 54(7):1405-10.
Score: 0.055
-
Something old, something new.... Leuk Lymphoma. 2006 Apr; 47(4):576-7.
Score: 0.034